COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,306 Articles (22,772 medRxiv, 8,534 bioRxiv)

Most recent first Previous |  Page 2517: Articles 25161-25170  | Next

Dengue antibodies can cross-react with SARS-CoV-2 and vice versa-Antibody detection kits can give false-positive results for both viruses in regions where both COVID-19 and Dengue co-exist
Nath, H., Mallick, A., Roy, S., Sukla, S., Basu, K., De, A., Biswas, S.
10.1101/2020.07.03.20145797 — Posted: 2020-07-06 Discussion: Onsite
Sample Pooling as an efficient strategy for SARS-COV-2 RT-PCR screening: a multicenter study in Spain
de Salazar, A., Aguilera, A., Trastoy, R., Fuentes, A., Alados, J. C., Causse, M., Galan, J. C., Moreno, A., Trigo, M., Perez, M., Roldan, C., Pena, M. J., Bernal, S., Serrano-Conde, E., Barbeito, G., Torres, E., Riazzo, C., Cortes-Cuevas, J. L., Chueca, N., Coira, A., Sanchez-Calvo, J. M., Marfil, E., Becerra, F., Gude, M. J., Pallares, A., Perez del Molino, M. L., Garcia, F.
10.1101/2020.07.04.20146027 — Posted: 2020-07-06
Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNA
Mannonen, L., Kallio-Kokko, H., Loginov, R., Jaaskelainen, A., Jokela, P., Antikainen, J., Vare, P., Kekalainen, E., Kurkela, S., Jarva, H., Lappalainen, M.
10.1101/2020.07.03.20144758 — Posted: 2020-07-06
Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19 positive patients compared to subjective methods: A systematic review and meta-analysis
Hannum, M. E., Ramirez, V. A., Lipson, S. J., Herriman, R. D., Toskala, A. K., Lin, C., Joseph, P. V., Reed, D. R.
10.1101/2020.07.04.20145870 — Posted: 2020-07-06
Foundational research and NIH funding enabling Emergency Use Authorization of remdesivir for COVID-19
Cleary, E. G., Jackson, M. J., Folchman-Wagner, Z., Ledley, F. D.
10.1101/2020.07.01.20144576 — Posted: 2020-07-06
Global Assessment of the Relationship between Government Response Measures and COVID-19 Deaths
Hale, T., Hale, A. J., Kira, B., Petherick, A., Phillips, T., Sridhar, D., Thompson, R., Webster, S., Angrist, N.
10.1101/2020.07.04.20145334 — Posted: 2020-07-06 Discussion: Onsite
Global pattern of COVID-19 research
Zhu, X., Jin, Q., Jiang, X., Dan, Y., Zhang, A., Qiu, G., Lou, J., Yu, H.
10.1101/2020.07.04.20146530 — Posted: 2020-07-06 Discussion: Onsite
Computational fluid dynamic (CFD), air flow-droplet dispersion, and indoor CO2 analysis for healthy public space configuration to complywith COVID 19 protocol
Adwibowo, A.
10.1101/2020.07.02.20145219 — Posted: 2020-07-06
Who is dying from Covid-19 in the United Kingdom? A review of cremation authorisations from a single South Wales' crematorium.
Salmon, R. L., Monaghan, S. P.
10.1101/2020.07.01.20136317 — Posted: 2020-07-06
A County-Level Susceptibility Index and Coronavirus Disease 2019 Mortality in the United States: A Socioecological Study
Khan, S., McCabe, M., Krefman, A., Petito, L. C., Yang, X., Kershaw, K., Pool, L., Allen, N. B.
10.1101/2020.07.04.20146084 — Posted: 2020-07-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).